A Study of Pirtobrutinib (LY3527727) in Participants With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Clinical trial NCT07218341 · RECRUITING
Trial details
- NCT number
- NCT07218341
- Sponsor
- Eli Lilly and Company
- Status
- RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-09
- Primary completion
- 2030-05-01
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.